AXL-BASED CANCER PATIENT SCREENING METHOD

Title:

AXL-BASED CANCER PATIENT SCREENING METHOD

Document Type and Number:

WIPO Patent Application WO/2019/050150

Kind Code:

A2

Abstract:

According to an embodiment of the present invention, provided is a screening method, for a lung cancer patient having acquired resistance to an EGFR therapeutic agent, by means of optical image analysis of blood circulating cancer cells and AXL.

More Like This:

JP2005291759	DISEASE DIAGNOSIS SYSTEM BY TWO-DIMENSIONAL IMAGE
WO/2022/203295	DIAGNOSIS SYSTEM USING FLUORESCENCE INFORMATION AND ACIDITY INFORMATION AND DIAGNOSIS METHOD USING SAME
JP2005003681	INFRARED THERMOGRAPHY

Inventors:

JEON BYUNG HEE (KR)

Application Number:

PCT/KR2018/008049

Publication Date:

March 14, 2019

Filing Date:

July 17, 2018

Export Citation:

Click for automatic bibliography generation Help

Assignee:

CYTOGEN INC (KR)

International Classes:

G01N33/483; G01N15/00; G01N15/14; G01N21/64; G01N33/574

Other References:

PARKIN DMBRAY FFERLAY JPISANI P: "Global cancer statistics", CA CANCER J CLIN, vol. 55, 2002, pages 74 - 108
SCHILLER JHHARRINGTON DBELANI CPLANGER CSANDLER AKROOK JZHU JJOHNSON DH: "Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer", N ENGL J MED, vol. 346, 2002, pages 92 - 98, XP002385282
See also references of EP 3680659A4

Attorney, Agent or Firm:

JIDAM IP LAW FIRM et al. (KR)

Download PDF:

View/Download PDF PDF Help

Previous Patent: PROSTATE-SPECIFIC MEMBRANE ANTIGEN-BASED PROSTATE CANCER PATIENT SCREENING METHOD

Next Patent: ELECTROSTATIC PRECIPITATOR UNIT FOR AIR PURIFIER AND AIR PURIFIER EMPLOYING SAME